Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News Experimental cancer therapy research continues at Birmingham New and innovative ways to detect and treat cancer being trialled at Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
29 June 2021 Blood cancer trial sponsored by the University of Birmingham opens for recruitment A new clinical trial being sponsored by the University of Birmingham has opened for recruitment aiming to investigate the efficacy of a novel treatment for patients affected by a specific type of blood cancer.
25 June 2021 Dr Lennard Lee awarded ACP McElwain Prize for contributions to medical oncology Dr Lennard Lee, Academic Clinical Lecturer at the University of Oxford/Honorary Research Fellow at the University of Birmingham, has been awarded the 2020 Association of Cancer Physicians (ACP) McElwain Prize.
27 May 2021 Study finds almost half of patients with inoperable pancreatic cancer are not prescribed essential medication A University of Birmingham-led study has found that almost half of patients with inoperable pancreatic cancer are not prescribed essential medication.
13 May 2021 NEC Laboratories Europe supports University's Birmingham-based innovative clinical cancer research NEC Laboratories Europe has agreed to donate to the Birmingham Institute of Head and Neck Studies and Education (InHANSE) to support its future cancer research.